Operationalizing GLP-1 Weight Loss Programs Turning GLP-1 business opportunities for pharmacies into consistent revenue requires planning
I've had patients who have engaged with some of these platforms but have ended up spending a lot of money and they've had difficulty getting appropriate counseling for long-term management of this
Related Reading Hers Vs Ro Hers Vs Hers Noom Vs Hers Medvi Vs Hers Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
Obesity is a major risk factor for cardiovascular disease, the leading cause of death in people with common arthritides such as osteoarthritis (OA), gout, rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis
- [The Economics of GLP-1 Receptor Agonists for Obesity]( *JAMA Health Forum*, 2024
The data acquired were low-pass filtered at 2 kHz, sampled at 10 kHz, and analyzed via PatchMaster and FitMaster (HEKA) software